Download Your 2026 Copy of the Agenda
The 3rd Novel Ingredients for Infant Formula Summit served as a definitive forum connecting R&D, regulatory, and commercial leaders with industry peers to share insights on advancing bioactive ingredients from discovery through approval and market entry. Together, attendees explored global submission pathways, aligned on evidence expectations, and addressed formulation and stability challenges, while examining the commercialisation of key ingredients such as HMOs, lactoferrin, osteopontin, lysozyme, and specialty lipids to drive compliant, scalable innovation in infant nutrition.
Having trouble downloading the brochure? Let us know and we’ll email it to you instead.